In this Season 3 premiere of The Business of AI in Healthcare, Dr. Robert Kaiser sits down with Henry O’Connell, CEO and Founder of Canary Speech, to explore one of the most talked-about frontiers in healthcare AI: voice biomarkers.
Together, they unpack how speech and language analytics can unlock medically meaningful signals, what it takes to move voice-based AI from research to real-world clinical workflows, and why this category is becoming increasingly relevant across neurology, behavioral health, and cognitive health.
If you’re a healthcare leader, innovator, investor, or technologist tracking AI diagnostics, clinical decision support, and the future of digital health, this conversation will sharpen how you think about what’s coming next.
Topics include: voice biomarkers, vocal biomarkers, speech analytics, AI in healthcare, clinical validation, ambient listening, machine learning in medicine, neurology, Alzheimer’s, Parkinson’s, depression screening, and clinical adoption.